Akèy › Gliyoblastòm › Colorado › Aurora
Etid klinik pou Gliyoblastòm nan Aurora, CO
12 etid pou Gliyoblastòm ap chèche patisipan nan sit nan ak bò kote Aurora (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Ap rekriteFaz 3
- UCHealth, Aurora
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Ap rekriteFaz 1/2
- UCHealth University of Colorado Hospital, Aurora
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Ap rekriteFaz 2/3
- University of Colorado Denver, Aurora
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Ap rekriteFaz 1/2
- Children's Hospital Colorado - Anschutz Medical Campus, Aurora
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Ap rekriteFaz 1/2
- UCHealth Cancer Center - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora
Targeted Pediatric High-Grade Glioma Therapy
Ap rekriteEtid obsèvasyon
- Children's Hospital Colorado, Aurora
Study of Olutasidenib and Temozolomide in HGG
Ap rekriteFaz 2
- Children's Hospital Colorado, Aurora
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Ap rekriteFaz 3
- University of Colorado Health Cancer Care, Aurora
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Ap rekriteFaz 1 bonèVolontè an sante akeyi
- Children's Hospital Colorado, Aurora
The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
Ap rekrite
- University of Colorado Anschutz Medical Campus, Aurora
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Ap rekriteFaz 2
- Children's Hospital Colorado, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Aurora
Etid Gliyoblastòm nan lòt vil
- New York City, NY30 etid
- Boston, MA28 etid
- Houston, TX26 etid
- Los Angeles, CA24 etid
- Durham, NC20 etid
- San Francisco, CA17 etid
- Chicago, IL15 etid
- Washington, DC15 etid
- Miami, FL14 etid
- Columbus, OH14 etid
- Rochester, MN13 etid
- Jacksonville, FL13 etid
Lòt etid nan Aurora
- Kansè (tout kalite)35 etid
- Kansè kolorektal32 etid
- Kansè Poumon ki pa ti selil31 etid
- Kansè nan tete28 etid
- Kansè ovè25 etid
- Kansè Metastatik25 etid
- Dyabèt tip 123 etid
- Obèsite22 etid
- Kansè pwostat19 etid
- Kansè poumon19 etid
- Ensifizyans kadyak18 etid
- Melanom18 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.